Dr. Arif Gulzar has obtained doctorate degree in Material Science and Engineering. His research focuses on cyclotron operation for the production of novel radioisotopes such as 68Ga etc and chelator free radiolabelling of nanoparticles for cancer theragnostic.
Reported by 9News, Clinical Director of The Florey Professor Graeme Jackson was interviewed about the technology developed at the Australian Epilepsy project.
26 June 2025
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
Dr Sicong Tu is excited about helping motor neurone disease (MND) patients gain a much better idea of their disease progression: “The focus of our network is on bridging the gap between leading Aust
28 May 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
Shota Hodono, Chia-Yin Wu, Jin Jin, Jonathan R. Polimeni, Martijn A. Cloos
Read Publication
Kerstin Glaus, William T. White, Helen L. O'Neill, Sarah Thurnheer, Sharon A. Appleyard
Read Publication
Melyssa L. Grieve, Patrick R. W. J. Davey, Paul V. Bernhardt, Craig M. Forsyth and Brett M. Paterson
Read Publication
Philip E. Mosley, Johan N. van der Meer, Lachlan H. W. Hamilton, Jurgen Fripp, Stephen Parker, Jayson Jeganathan, Michael Breakspear, Richard Parker, Rebecca Holland, Brittany L. Mitchell, Enda Byrne, Ian B. Hickie, Sarah E. Medland, Nicholas G. Martin & Luca Cocchi
Read Publication